Key Points
- Scott Moomaw, a Liquidia insider, sold 18,314 shares on March 23 at an average price of $36.79 for about $673,772, cutting his stake by 8.89% to 187,640 shares (≈$6.9M).
- Earnings beat: Liquidia reported $0.15 EPS vs. $0.08 expected and revenue of $92.02M (up 3,072% year‑over‑year), but remains unprofitable with a -43.53% net margin and negative ROE.
- Analysts are generally positive with a consensus "Moderate Buy" and $43.44 price target; the stock trades near $36.6 with a $3.23B market cap and a 12‑month range of $11.26–$46.67.
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Scott Moomaw sold 18,314 shares of Liquidia stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average price of $36.79, for a total transaction of $673,772.06. Following the completion of the sale, the insider owned 187,640 shares of the company's stock, valued at $6,903,275.60. This trade represents a 8.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Scott Moomaw also recently made the following trade(s):
- On Monday, January 12th, Scott Moomaw sold 20,533 shares of Liquidia stock. The shares were sold at an average price of $37.43, for a total transaction of $768,550.19.
Liquidia Trading Up 4.0%
NASDAQ LQDA opened at $36.61 on Thursday. Liquidia Corporation has a 12-month low of $11.26 and a 12-month high of $46.67. The company has a fifty day simple moving average of $37.74 and a two-hundred day simple moving average of $31.73. The company has a current ratio of 2.01, a quick ratio of 1.84 and a debt-to-equity ratio of 2.97. The stock has a market cap of $3.23 billion, a P/E ratio of -44.11 and a beta of 0.52.
Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.08 by $0.07. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The firm had revenue of $92.02 million for the quarter, compared to analyst estimates of $87.49 million. The firm's revenue for the quarter was up 3072.4% compared to the same quarter last year. On average, analysts forecast that Liquidia Corporation will post -1.51 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on the company. Jefferies Financial Group increased their price objective on Liquidia from $45.00 to $55.00 and gave the company a "buy" rating in a report on Tuesday, January 13th. Oppenheimer lifted their target price on Liquidia from $16.00 to $19.00 and gave the stock an "underperform" rating in a report on Thursday, March 12th. Raymond James Financial reiterated a "strong-buy" rating on shares of Liquidia in a research report on Thursday, March 5th. Needham & Company LLC increased their price target on shares of Liquidia from $52.00 to $54.00 and gave the stock a "buy" rating in a report on Thursday, March 5th. Finally, Wells Fargo & Company raised their price target on shares of Liquidia from $44.00 to $51.00 and gave the stock an "overweight" rating in a research report on Monday. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $43.44.
View Our Latest Stock Analysis on Liquidia
Institutional Investors Weigh In On Liquidia
Several hedge funds have recently added to or reduced their stakes in LQDA. Northwestern Mutual Wealth Management Co. acquired a new stake in Liquidia during the 4th quarter worth about $25,000. Covestor Ltd boosted its stake in shares of Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company's stock worth $42,000 after buying an additional 359 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in Liquidia during the third quarter worth about $30,000. FNY Investment Advisers LLC acquired a new stake in Liquidia during the third quarter worth about $34,000. Finally, NewEdge Advisors LLC purchased a new position in Liquidia during the second quarter valued at approximately $25,000. 64.54% of the stock is owned by hedge funds and other institutional investors.
About Liquidia
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
